Semaglutide

含有 Semaglutide 的品牌、食物注意事项以及最重要的药物相互作用。

品牌

OZEMPIC 0.25 MG ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR KALEM (1 ADET)条形码：8699676950300
OZEMPIC 0.50 MG ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR KALEM (1 ADET)条形码：8699676950317
OZEMPIC 1 MG ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR KALEM (1 ADET)条形码：8699676950324
WEGOVY 0.25 MG ENJEKSIYONLUK COZELTI IÇEREN KULLANIMA HAZIR KALEM (1 KALEM)条形码：8699676951321
WEGOVY 0.5 MG ENJEKSIYONLUK COZELTI IÇEREN KULLANIMA HAZIR KALEM (1 KALEM)条形码：8699676951338
WEGOVY 1 MG ENJEKSIYONLUK COZELTI IÇEREN KULLANIMA HAZIR KALEM (1 KALEM)条形码：8699676951345
WEGOVY 1,7 MG ENJEKSIYONLUK COZELTI IÇEREN KULLANIMA HAZIR KALEM (1 KALEM)条形码：8699676951352
WEGOVY 2,4 MG ENJEKSIYONLUK COZELTI IÇEREN KULLANIMA HAZIR KALEM (1 KALEM)条形码：8699676951369

食物注意事项

空腹服用。口服 semaglutide 应在当天第一餐前 30 分钟服用。
模板翻译
用白开水送服。口服 semaglutide 时，饮水量请勿超过 4 盎司（半杯）水。
模板翻译

最重要的相互作用

前 10 项，共 50 项

2,4-thiazolidinedione中等
当 2,4-thiazolidinedione 与 Semaglutide 联合使用时，发生低血糖的风险或严重程度可能增加。
专业视图
The risk or severity of hypoglycemia can be increased when 2,4-thiazolidinedione is combined with Semaglutide.
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline中等
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline 可能增强 Semaglutide 的降血糖作用。
专业视图
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Semaglutide.
Acarbose中等
当 Acarbose 与 Semaglutide 联合使用时，发生低血糖的风险或严重程度可能增加。
专业视图
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Semaglutide.
Acetohexamide中等
Semaglutide 可能增强 Acetohexamide 的降血糖作用。
专业视图
Semaglutide may increase the hypoglycemic activities of Acetohexamide.
Acetylsalicylic acid中等
当 Acetylsalicylic acid 与 Semaglutide 联合使用时，发生低血糖的风险或严重程度可能增加。
专业视图
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Semaglutide.
Agmatine中等
当 Agmatine 与 Semaglutide 联合使用时，发生低血糖的风险或严重程度可能增加。
专业视图
The risk or severity of hypoglycemia can be increased when Agmatine is combined with Semaglutide.
AICA ribonucleotide中等
当 AICA ribonucleotide 与 Semaglutide 联合使用时，发生低血糖的风险或严重程度可能增加。
专业视图
The risk or severity of hypoglycemia can be increased when AICA ribonucleotide is combined with Semaglutide.
Alaproclate中等
当 Alaproclate 与 Semaglutide 联合使用时，发生低血糖的风险或严重程度可能增加。
专业视图
The risk or severity of hypoglycemia can be increased when Alaproclate is combined with Semaglutide.
Albiglutide中等
当 Albiglutide 与 Semaglutide 联合使用时，发生低血糖的风险或严重程度可能增加。
专业视图
The risk or severity of hypoglycemia can be increased when Albiglutide is combined with Semaglutide.
Albusomatropin中等
Albusomatropin 可能减弱 Semaglutide 的降血糖作用。
专业视图
Albusomatropin may decrease the hypoglycemic activities of Semaglutide.